Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189,952 | 165,596 | 174,858 | 192,037 | 157,132 |
| Marketable Securities | 278,141 | 248,478 | 177,244 | 115,745 | 111,208 |
| Receivables | 23,224 | 15,594 | 51,742 | 31,910 | 40,065 |
| Inventories | 73,141 | 54,895 | 41,396 | 48,181 | 22,069 |
| TOTAL | $594,172 | $527,177 | $475,530 | $420,311 | $355,907 |
| Non-Current Assets | |||||
| PPE Net | 1,986 | 1,943 | 1,655 | 1,076 | 606 |
| Intangibles | 15,000 | 15,250 | 15,500 | 15,750 | 16,000 |
| Other Non-Current Assets | 214,122 | 219,263 | 219,648 | 224,013 | 226,813 |
| TOTAL | $231,108 | $236,456 | $236,803 | $240,839 | $243,419 |
| Total Assets | $825,280 | $763,633 | $712,333 | $661,150 | $599,326 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,402 | 2,028 | 6,150 | 8,956 | 1,982 |
| Accrued Expenses | 108,348 | 112,035 | 94,223 | 88,348 | 75,901 |
| Other current liabilities | 20,691 | 22,134 | 20,523 | 18,001 | 17,092 |
| TOTAL | $156,611 | $139,184 | $123,592 | $117,827 | $97,267 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 31,171 | 25,032 | 21,547 | 16,505 | 12,759 |
| TOTAL | $62,982 | $56,843 | $53,358 | $48,316 | $44,570 |
| Total Liabilities | $219,593 | $196,027 | $176,950 | $166,143 | $141,837 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,938 | 76,535 | 75,796 | 74,108 | 72,971 |
| Common Shares | 21 | 21 | 21 | 21 | 20 |
| Retained earnings | -439,546 | -462,138 | -476,337 | -494,772 | -512,604 |
| Other shareholders' equity | -665 | -25 | -155 | -53 | -165 |
| TOTAL | $605,687 | $567,606 | $535,383 | $495,007 | $457,489 |
| Total Liabilities And Equity | $825,280 | $763,633 | $712,333 | $661,150 | $599,326 |